Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-09

Clinical Trial Update: Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). [Phase 4]

View source ↗

Summary

A Phase 4 trial update on de-prescribing beta blockers after coronary artery bypass graft surgery, investigating safety/efficacy implications of reducing beta-b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: University of Saskatchewan | Conditions: Coronary Artery Disease, Acute Myocardial Infarction | Phase 4 | Status: UNKNOWN